Comparative QSAR Studies on the Novel Series of Thiazolones and Tetrazole Derivatives as HCV NS5B Polymerase Allosteric Inhibitors

By  

Letters in Drug Design & Discovery, Vol. 6, Iss. 4, 2009-06 ,pp. : 286-297

Bentham Science Publishers

Access to resources Recommend Favorite

Hepatitis C therapy with HCV NS5B polymerase inhibitors

By Soriano Vincent   Vispo Eugenia   de Mendoza Carmen   Labarga Pablo   Fernandez-Montero Jose Vicente   Poveda Eva   Treviño Ana   Barreiro Pablo  

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 9, 2013-06 ,pp. : 1161-1170

Informa Healthcare

Access to resources Recommend Favorite

QSAR and Molecular Modeling Studies on a Series of Indole-based Pyridone Analogues as HCV NS5B Polymerase Inhibitors

By  

Letters in Drug Design & Discovery, Vol. 13, Iss. 8, 2016-10 ,pp. : 757-770

Bentham Science Publishers

Access to resources Recommend Favorite

Allosteric Inhibitors of Hepatitis C NS5B RNA-dependent RNA Polymerase°

By  

Current Medicinal Chemistry - Anti-Infective Agents, Vol. 4, Iss. 2, 2005-04 ,pp. : 99-110

Bentham Science Publishers

Access to resources Recommend Favorite

Non-Nucleoside Inhibitors of NS5B Polymerase Binding to Allosteric Sites: 3DQSAR and Molecular Docking Studies

By  

Current Medicinal Chemistry, Vol. 15, Iss. 15, 2008-06 ,pp. : 1462-1477

Bentham Science Publishers

Access to resources Recommend Favorite